Search results for: 'point pharmaceutical'

Patent expiration and increased use of traditional generic drugs are leading to a shift of focus in the pharmaceutical industry toward investment in specialty drugs and high growth areas such as biosimilars. Expensive biopharmaceuticals are largely used for life-saving disorders such as cancer and diabetes, the incidence of which is increasing with...

27 Nov 2017  |  North America  |  Market Research

Growth Opportunities in the Global Digital Pathology Market, Forecast to 2021

New Business Models and More FDA Approvals of WSI Scanners for Primary Diagnostics are Set to Boost Growth of Digital Pathology

Infographics

×

Key Issues Addressed

Shortage of pathologists and the rise in new cancer cases are the key drivers for the adoption of digital pathology solutions globally. Digital pathology enhances the productivity of pathologists by 10% to 15%, thereby improving the overall efficiency of healthcare providers. Digital pathology solutions find the best fit in oncology care. Accordin...

10 Jan 2018  |  Asia Pacific  |  Market Research

APAC Biosimilar Market, Forecast 2025

Patent Expiries, Defined Regulatory Pathways, and Escalating Healthcare Costs to Boost Growth

Infographics

×

Key Issues Addressed Key Benefits

Biosimilars is a massive opportunity; regardless of a slow start, the market will eventually be a huge business. As per Frost & Sullivan’s estimate, biologic drugs worth $70–$80 billion will lose exclusivity in the next 5 years globally and APAC’s contribution would be more than 20%. Countries in the region, such as India, China, and South Korea, o...

Expanding use cases of autonomous solutions are expected to make future homes very smart. Evolution of Artificial Intelligence will entail the use of robotics across myriad functions that cater to various industries. The increasing number of start-up firms and M&A activity parallels the growth of emerging AI technology, such as machine learning app...

10 Dec 2020  |    |  Megatrends

Nine Mega Trends Radically Accelerated by COVID-19

Convergence of Mega Trends will Generate New Growth Opportunities

Infographics

×

Frost & Sullivans Mega Trend Universe encompasses transformative, global forces that define the future world with their far-reaching impact on businesses, economics, cultures, and personal lives. Disruption of the global economy, industry, companies, and investments are making it difficult for companies to prepare for the future. The emergence of a...

16 Apr 2018  |  Global  |  Megatrends

The Future of Last-mile Delivery Bots

The Global Delivery Bot Market is likely to Reach $16.79 Billion by 2030

Infographics

×

The logistics market is currently undergoing a major transformation with new innovative solutions determining the way goods are being delivered from point A to point B. The market is witnessing influx of new breed of tech-savvy startups that are coming up with unique business models and services that are largely disrupting the supply chain ecosyste...

Supply chain in any organization is literally its backbone. Cutting across a range of functions, it traverses across the life cycle of a product. Even a slight impediment can affect the entire value chain, run schedules off track, and significantly hamper productivity and efficiency. As companies struggle with visibility and transparency in the tra...

Frost & Sullivan’s Trend Opportunity Profiles are designed to help clients discover and prioritize the most consequential mid-to-long term trends transforming their business growth environment. To create each profile, Frost & Sullivan analyzes the trend opportunity across key industries, including aerospace and defense; health, wellness, and well-b...

This study features emerging Trend Opportunity Profiles that share novel business outlooks in the form of models, which offer convenience to customers and profit to owners through advanced technology usage, increased digital presence, and strategic collaborations. With a shift to convenience and ease of access as the focal point for consumers, c...